english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Paracetamol: patients need to be more aware of the harms

Secondary cardiovascular prevention: dubious benefits of evolocumab (Repatha°) and alirocumab (Praluent°)

Trials funded by drug companies: publication or publicity?

Erenumab (Aimovig°) for the prevention of migraine attacks: decrease in the frequency of attacks in some patients, but uncertainty over cardiovascular effects

In the September edition of Prescrire International: sartan medicines contaminated by impurities which are probable carcinogens

Carpal tunnel syndrome: sometimes drug-related

New drugs: investing in more informative clinical trials

Fluoroquinolones: use should be restricted due to severe adverse effects

"Top Texts of 2019", new from the editors of Prescrire International

Psychotic episode: which oral neuroleptic to choose? A choice tailored to each patient, based on the adverse effect profiles of the options

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90